News & Publications for:

Eric Lenze

Doctors test popular anti-depressant to see if it fights off Covid-19

Posted on January 11, 2021

Doctors are running a clinical trial to see if a popular anti-depressant might keep someone from becoming severely ill with Covid-19. Read More

Posted in: Neurogenetics & Transcriptomics, NeuroRestorative Therapy, News Faculty:

Podcast: Vaccines have arrived but COVID-19 treatments progressing much more slowly

Posted on December 29, 2020

From the WashU School of Medicine News… A new episode of our podcast, “Show Me the Science,” has been posted. At present, these podcast episodes are highlighting research and patient care on the Washington University Medical Campus as our scientists and clinicians confront the COVID-19 pandemic. COVID-19 vaccine development has been rapid and successful. Two vaccines that report more than 90% efficacy against the virus already are in use, with approval of more vaccines expected … Read More

Posted in: Neurogenetics & Transcriptomics, NeuroRestorative Therapy, News Faculty:

Fluvoxamine may prevent serious illness in COVID-19 patients

Posted on November 13, 2020

Antidepressant drug repurposed for patients with coronavirus infection Read More

Posted in: Neurogenetics & Transcriptomics, NeuroRestorative Therapy, News Faculty:

Coprescribed Benzodiazepines in Older Adults Receiving Antidepressants for Anxiety and Depressive Disorders: Association With Treatment Outcomes

Posted on October 23, 2020

Helene Altmann, Sarah T. Stahl, Marie Anne Gebara, Eric J. Lenze, Benoit H. Mulsant, Daniel M. Blumberger, Charles F. Reynolds III and Jordan F. Karp. The Journal of Clinical Psychiatry, Volume 81, Issue 6, 29 September 2020 Read More

Posted in: Neurogenetics & Transcriptomics, NeuroRestorative Therapy, Publications Faculty: